Belen Lloveras
Overview
Explore the profile of Belen Lloveras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
3303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lop Gros J, Santiago Diaz P, Larrubia Loring M, Patriarca M, Lloveras B, Iglesias M
Appl Immunohistochem Mol Morphol
. 2025 Feb;
33(2):61-69.
PMID: 39894972
Claudin 18.2 is a transmembrane protein, part of the tight-junction complex, selectively expressed in gastric epithelium. It is showing promising results as a target in advanced gastric cancer in phase...
2.
Fernandez-Nestosa M, Sanchez D, Canete-Portillo S, Alemany L, Clavero O, Lloveras B, et al.
Int J Surg Pathol
. 2024 Nov;
:10668969241295352.
PMID: 39535004
Squamous cell carcinomas with two or more coexisting clearly different histological subtypes of penile carcinomas are designated as mixed carcinomas in current classification models. They represent about 10% of all...
3.
Bellosillo B, Ibanez R, Roura E, Monfil L, Asensio-Puig L, Alvarez I, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611001
Many scientific societies have issued guidelines to introduce population-based cervical cancer screening with HPV testing. The Vitro HPV Screening assay is a fully automatic multiplex real-time PCR test targeting the...
4.
Gonzalez-Farre M, Gibert J, Santiago-Diaz P, Menendez S, Monzonis X, Olivares F, et al.
Hum Pathol
. 2023 Jul;
139:91-105.
PMID: 37517596
Stromal tumor-infiltrating lymphocytes (sTILs) are a robust prognostic and predictive biomarker in triple-negative breast carcinoma. However, the sTIL compartment comprises different cell populations. The aim of the study is to...
5.
Gonzalez-Farre M, Gibert J, Santiago-Diaz P, Santos J, Garcia P, Masso J, et al.
Virchows Arch
. 2023 Jul;
483(5):655-663.
PMID: 37500796
Stromal tumour infiltrating lymphocytes (sTIL) in haematoxylin and eosin (H&E) stained sections has been linked to better outcomes and better responses to neoadjuvant therapy in triple-negative and HER2-positive breast cancer...
6.
Sanchez D, Fernandez-Nestosa M, Alemany L, Canete-Portillo S, Lloveras B, Clavero O, et al.
Hum Pathol
. 2023 Jul;
139:65-72.
PMID: 37429448
Human papillomavirus (HPV) is detected in 30-50% of invasive penile carcinomas, and it is frequently associated with basaloid and warty morphological features. Based on this heterogeneity and different clinical behaviors,...
7.
Ribas A, Puche A, Gimeno J, Sans L, Barrios C, Marquez E, et al.
Clin Kidney J
. 2022 Feb;
15(3):417-424.
PMID: 35211301
Background: Renal manifestations of monoclonal gammopathies are of increasing interest among nephrologists. Typical manifestations include light chain cast nephropathy, amyloidosis or renal damage mediated by monoclonal immunoglobulin deposition. Podocytopathies in...
8.
Guardia C, Bianchini G, Arpi-Llucia O, Menendez S, Casadevall D, Galbardi B, et al.
Clin Cancer Res
. 2021 Aug;
27(18):5096-5108.
PMID: 34385295
Purpose: To characterize expression of neuregulin-1 (NRG1), an HER3 ligand, in HER2-positive breast cancer and its relation with the efficacy of trastuzumab with or without pertuzumab. Experimental Design: Characterization of...
9.
Salvado A, Miralpeix E, Sole-Sedeno J, Kanjou N, Lloveras B, Duran X, et al.
Gynecol Oncol
. 2021 Jul;
162(3):569-574.
PMID: 34226019
Objective: The purpose of this study was to evaluate the role of HPV genotyping and previous cytology result to predict the evolution of CIN2 histological lesions managed conservatively. Methods: A...
10.
Mancebo G, Miralpeix E, Sole-Sedeno J, Tio G, Rodrigo-Calvo T, Lloveras B, et al.
Eur J Obstet Gynecol Reprod Biol
. 2021 May;
262:68-72.
PMID: 33991774
Objective: Invasive cervical cancer is considered a young women's disease, however up to 20 % of cases develop cervical cancer at advanced ages. The aim was to characterize invasive cervical...